Chronic treatment with mood stabilizers increases membrane GRK3 in rat frontal cortex
Chronic treatment with mood stabilizers increases membrane GRK3 in rat frontal cortex
复制标题
DOI:
10.1016/j.biopsych.2006.03.022
复制
发表时间:
2007-01-15
影响因子:
10.6
通讯作者:
Rao, Jagadeesh S.
中科院分区:
文献类型:
--
作者:
Ertley, Renee N.;Bazinet, Richard P.;Rao, Jagadeesh S.
Background: G-protein receptor kinases (GRKs) are a family of serine/threonine kinases involved in the homologous desensitization of agonist activated G-protein coupled receptors (GPCRs). G-protein coupled receptor supersensitivity, possibly as a result of decreased in affective disorders. GRK, has been suggested inMethods: We used immunobloting to determine if chronic, therapeutically relevant doses of lithium (Li+), carbamazepine (CBZ), and valproate (VPA), would increase GRK2/3 protein levels in rat frontal cortex.Results: Chronic Li+ (24%) and CBZ (44%) signficantly increased GRK3 in the membrane but not cytosol fractions. Chronic VPA bad no effect on GRK3. G-protein receptor kinase 2 protein levels were unchanged by all treatments. The GRK3 membrane to cytosol ratio was increased significantly in Li+ and CBZ treated rats.Conclusions: These results show that chronically administered Li+ and CBZ, but not VPA, increase the translocation of GRK3 from cytosol to membrane, possibly correcting supersensitivity of GPCRs in bipolar disorder.